Advanced search
Publication Cover
Acta Oncologica Volume 46, 2007 - Issue 6
Journal homepage
1,156
Views
52
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas

Marie-Louise Fjällskog Departments of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala, SwedenCorrespondence[email protected]
,
Ola Hessman Department of Surgical Sciences, University Hospital, Uppsala, Sweden
,
Barbro Eriksson Department of Medical Sciences, University Hospital, Uppsala, Sweden
&
Eva Tiensuu Janson Department of Medical Sciences, University Hospital, Uppsala, Sweden
Pages 741-746 | Received 31 Jul 2006, Published online: 08 Jul 2009

Citations (52)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Nicola Fazio, Chiara A. Cella, Marzia Del Re, Alice Laffi, Manila Rubino, Paola Zagami & Francesca Spada. (2019) Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors. Expert Opinion on Drug Metabolism & Toxicology 15:12, pages 993-1004.
Read now
Jianpeng Chen, Caixia Wang, Junqing Han, Yi Luan, Yangang Cui, Rong Shen, Dan Sha, Lei Cong, Zheng Zhang & Weibo Wang. (2013) Therapeutic effect of sunitinib malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma. Expert Review of Anticancer Therapy 13:6, pages 737-743.
Read now
Savita Bisht, Georg Feldmann & Peter Brossart. (2013) Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors. Expert Opinion on Drug Metabolism & Toxicology 9:6, pages 777-788.
Read now
Vincenzo Marotta, Maria Domenica Franzese, Michela Del Prete, Maria Grazia Chiofalo, Valeria Ramundo, Raffaella Esposito, Francesca Marciello, Luciano Pezzullo, Annachiara Carratù, Mario Vitale, Annamaria Colao & Antongiulio Faggiano. (2013) Targeted therapy with kinase inhibitors in aggressive endocrine tumors. Expert Opinion on Pharmacotherapy 14:9, pages 1187-1203.
Read now
Ferdinando Riccardi, Mimma Rizzo, Lucia Festino, Francesca Ambrosio, Carlo Molino, Generoso Uomo & Giacomo Cartenì. (2012) Therapy innovation for the treatment of pancreatic neuroendocrine tumors. Expert Opinion on Therapeutic Targets 16:sup2, pages S91-S102.
Read now
Georgios Baltogiannis, Christos Katsios & Dimitrios H Roukos. (2011) New target therapies for patients with neuroendocrine tumors of the pancreas. Expert Review of Gastroenterology & Hepatology 5:5, pages 563-566.
Read now

Articles from other publishers (46)

Karl Knipper, Alexander I. Damanakis, Yue Zhao, Christiane J. Bruns, Thomas Schmidt, Felix C. Popp, Alexander Quaas & Su Ir Lyu. (2023) Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma. Cancers 15:7, pages 2049.
Crossref
Xin Gao, Haoran Xu, Zhuoyi Ye, Xin Chen, Xin Wang, Qi Chang & Yueqing Gu. (2022) PDGFRβ targeted innovative imaging probe for pancreatic adenocarcinoma detection. Talanta, pages 124225.
Crossref
Thomas Cuny, Peter M. van Koetsveld, Grégoire Mondielli, Fadime Dogan, Wouter W. de Herder, Anne Barlier & Leo J. Hofland. (2022) Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment. Cancers 14:14, pages 3481.
Crossref
Amy ChangScott K. ShermanJames R. HoweVaibhav Sahai. (2022) Progress in the Management of Pancreatic Neuroendocrine Tumors. Annual Review of Medicine 73:1, pages 213-229.
Crossref
Shaoshan Mai & Iwona Inkielewicz-Stepniak. (2021) Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target. Frontiers in Cell and Developmental Biology 9.
Crossref
Chandra Maharjan, Po Ear, Catherine Tran, James Howe, Chandrikha Chandrasekharan & Dawn Quelle. (2021) Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. Cancers 13:20, pages 5117.
Crossref
Hsin-Han Yang, Jen-Wei Liu, Jui-Hao Lee, Horng-Jyh Harn & Tzyy-Wen Chiou. (2021) Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor. International Journal of Molecular Sciences 22:15, pages 8125.
Crossref
Rui Jiang, Xiafei Hong, Yupei Zhao & Wenming Wu. (2021) Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms. Cancer Letters 499, pages 39-48.
Crossref
Masanao ICHIMATA, Shinichiro NISHIYAMA, Fukiko MATSUYAMA, Eri FUKAZAWA, Kei HARADA, Ryuzo KATAYAMA, Atsushi TOSHIMA, Yumiko KAGAWA, Tetsushi YAMAGAMI & Tetsuya KOBAYASHI. (2021) Long-term survival in a dog with primary hepatic neuroendocrine tumor treated with toceranib phosphate. Journal of Veterinary Medical Science 83:10, pages 1554-1558.
Crossref
Nicola Fazio, Matthew Kulke, Brad Rosbrook, Kathrine Fernandez & Eric Raymond. (2021) Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib. Targeted Oncology 16:1, pages 27-35.
Crossref
Namrata Vijayvergia & Arvind Dasari. (2020) Targeted Therapies in the Management of Well-Differentiated Digestive and Lung Neuroendocrine Neoplasms. Current Treatment Options in Oncology 21:12.
Crossref
Chandrikha Chandrasekharan. (2020) Medical Management of Gastroenteropancreatic Neuroendocrine Tumors. Surgical Oncology Clinics of North America 29:2, pages 293-316.
Crossref
Juan W Valle, Ivan Borbath, Brad Rosbrook, Kathrine Fernandez & Eric Raymond. (2019) Sunitinib in patients with pancreatic neuroendocrine tumors: update of safety data. Future Oncology 15:11, pages 1219-1230.
Crossref
Tetsuhide Ito, Masayuki Tori, Satoshi Hashigaki, Nobuyuki Kimura, Kazuo Sato, Emiko Ohki, Akira Sawaki & Takuji Okusaka. (2019) Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study. Japanese Journal of Clinical Oncology 49:4, pages 354-360.
Crossref
Kazuo Sato, Yasuharu Toyoshima, Shiho Moriyama, Yutaka Endo, Tetsuhide Ito & Emiko Ohki. (2018) Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study. Cancer Chemotherapy and Pharmacology 83:1, pages 201-207.
Crossref
Thomas Cuny, Wouter de Herder, Anne Barlier & Leo J Hofland. (2018) Role of the tumor microenvironment in digestive neuroendocrine tumors. Endocrine-Related Cancer 25:11, pages R519-R544.
Crossref
Buket Onel, Megan Carver, Prashansa Agrawal, Laurence H. Hurley & Danzhou Yang. (2018) The 3′-end region of the human PDGFR-β core promoter nuclease hypersensitive element forms a mixture of two unique end-insertion G-quadruplexes. Biochimica et Biophysica Acta (BBA) - General Subjects 1862:4, pages 846-854.
Crossref
Xavier M. Keutgen, Suresh Kumar, Sudheer Gara, Myriem Boufraqech, Sunita Agarwal, Ralph H. Hruban, Naris Nilubol, Martha Quezado, Richard Finney, Maggie Cam & Electron Kebebew. (2018) Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype. Cancer 124:3, pages 636-647.
Crossref
Izumi Komoto, Yohei Hosoda & Masayuki Imamura. 2018. Molecular Diagnosis and Targeting for Thoracic and Gastrointestinal Malignancy. Molecular Diagnosis and Targeting for Thoracic and Gastrointestinal Malignancy 145 156 .
E. Treggiari, L. Ressel, G. A. Polton, J. Benoit, I. Desmas & L. Blackwood. (2017) Clinical outcome, PDGFRβ and KIT expression in feline histiocytic disorders: a multicentre study. Veterinary and Comparative Oncology 15:1, pages 65-77.
Crossref
Jennifer A. Chan & Matthew H. Kulke. (2016) Medical Management of Pancreatic Neuroendocrine Tumors. Surgical Oncology Clinics of North America 25:2, pages 423-437.
Crossref
Eliane CortezHanna GladhSebastian BraunMatteo BocciEugenia CorderoNiklas K. BjörkströmHideki MiyazakiIacovos P. Michael, Ulf ErikssonErika FolestadKristian Pietras. (2016) Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD. Proceedings of the National Academy of Sciences 113:7.
Crossref
Ian W Folkert, Paul Hernandez & Robert E Roses. (2016) Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas. World Journal of Gastroenterology 22:11, pages 3105.
Crossref
Aejaz Nasir, Ujalla Sheikh, Jalil Muhammad & Domenico Coppola. 2016. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances 457 469 .
Chiara Alessandra Cella, Saverio Minucci, Francesca Spada, Salvatore Galdy, Mohamed Elgendy, Paola Simona Ravenda, Maria Giulia Zampino, Sabina Murgioni & Nicola Fazio. (2015) Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: From bench to bedside. Cancer Treatment Reviews 41:9, pages 754-760.
Crossref
Rouzbeh Daylami, Dhruvil Shah & Richard J. Bold. 2015. Surgical Oncology. Surgical Oncology 563 572 .
Jennifer Chan & Matthew Kulke. (2014) Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors. Current Treatment Options in Oncology 15:3, pages 365-379.
Crossref
Sahar Hiram-Bab, Liora S. Katz, Hagit Shapira, Judith Sandbank, Marvin C. Gershengorn & Yoram Oron. (2014) Platelet-Derived Growth Factor BB Mimics Serum-Induced Dispersal of Pancreatic Epithelial Cell Clusters. Journal of Cellular Physiology 229:6, pages 743-751.
Crossref
Amal Imbulgoda, Daniel Y. C. Heng & Christian Kollmannsberger. 2014. Small Molecules in Oncology. Small Molecules in Oncology 165 184 .
Weidong Jiang, Ruochun Huang, Chaohui Duan, Liwu Fu, Yun Xi, Yuebo Yang, Wei-Min Yang, Dongzi Yang, Dong-Hua Yang & Ruo-Pan Huang. (2013) Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays. PLoS ONE 8:10, pages e76795.
Crossref
Jianliang Zhang, Rony Francois, Renuka Iyer, Mukund Seshadri, Maria Zajac-Kaye & Steven N. Hochwald. (2013) Current Understanding of the Molecular Biology of Pancreatic Neuroendocrine Tumors. JNCI: Journal of the National Cancer Institute 105:14, pages 1005-1017.
Crossref
Jennifer A. Chan, Robert J. Mayer, Nadine Jackson, Paige Malinowski, Eileen Regan & Matthew H. Kulke. (2013) Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors. Cancer Chemotherapy and Pharmacology 71:5, pages 1241-1246.
Crossref
Christine Vestergaard Madsen, Karina Dahl Steffensen, Marianne Waldstrøm & Anders Jakobsen. (2012) Immunohistochemical Expression of Platelet-Derived Growth Factor Receptors in Ovarian Cancer Patients with Long-Term Follow-Up. Pathology Research International 2012, pages 1-8.
Crossref
Roeland F. de Wilde, Barish H. Edil, Ralph H. Hruban & Anirban Maitra. (2012) Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy. Nature Reviews Gastroenterology & Hepatology 9:4, pages 199-208.
Crossref
Mark A. Lewis & Timothy J. Hobday. (2012) Treatment of Neuroendocrine Tumor Liver Metastases. International Journal of Hepatology 2012, pages 1-12.
Crossref
Theodore Liakakos & Dimitrios H Roukos. (2011) Everolimus and sunitinib: from mouse models to treatment of pancreatic neuroendocrine tumors. Future Oncology 7:9, pages 1025-1029.
Crossref
Daniel Castellano, Ramón Salazar & Eric Raymond. (2011) Future perspectives on neuroendocrine tumors. Cancer and Metastasis Reviews 30:S1, pages 35-40.
Crossref
Eric Raymond, Timothy Hobday, Daniel Castellano, Diane Reidy-Lagunes, Rocío García-Carbonero & Alfredo Carrato. (2011) Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors. Cancer and Metastasis Reviews 30:S1, pages 19-26.
Crossref
Eric Raymond, Laetitia Dahan, Jean-Luc Raoul, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Juan Valle, Peter Metrakos, Denis Smith, Aaron Vinik, Jen-Shi Chen, Dieter Hörsch, Pascal Hammel, Bertram Wiedenmann, Eric Van Cutsem, Shem Patyna, Dongrui Ray Lu, Carolyn Blanckmeister, Richard Chao & Philippe Ruszniewski. (2011) Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors. New England Journal of Medicine 364:6, pages 501-513.
Crossref
Sandrine Faivre, Marie-Paule Sablin, Chantal Dreyer & Eric Raymond. (2010) Novel Anticancer Agents in Clinical Trials for Well-Differentiated Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 39:4, pages 811-826.
Crossref
Reginald Hill, Joseph Hargan Calvopina, Christine Kim, Ying Wang, David W. Dawson, Timothy R. Donahue, Sarah Dry & Hong Wu. (2010) PTEN Loss Accelerates Kras G12D -Induced Pancreatic Cancer Development . Cancer Research 70:18, pages 7114-7124.
Crossref
Yong Qin, Jessica S. Fortin, Denise Tye, Mary Gleason-Guzman, Tracy A. Brooks & Laurence H. Hurley. (2010) Molecular Cloning of the Human Platelet-Derived Growth Factor Receptor β (PDGFR-β) Promoter and Drug Targeting of the G-Quadruplex-Forming Region To Repress PDGFR-β Expression. Biochemistry 49:19, pages 4208-4219.
Crossref
Amanda F. Baker & Tomislav Dragovich. 2010. Drug Discovery in Pancreatic Cancer. Drug Discovery in Pancreatic Cancer 271 289 .
Stefano La Rosa, Daniela Furlan, Fausto Sessa & Carlo Capella. 2010. Endocrine Pathology:. Endocrine Pathology: 367 413 .
Paola Capelli, Guido Martignoni, Federica Pedica, Massimo Falconi, Davide Antonello, Giorgio Malpeli & Aldo Scarpa. (2009) Endocrine Neoplasms of the Pancreas: Pathologic and Genetic Features. Archives of Pathology & Laboratory Medicine 133:3, pages 350-364.
Crossref
D. Antonello, S. Gobbo, V. Corbo, B. Sipos, N.R. Lemoine & A. Scarpa. (2009) Update on the Molecular Pathogenesis of Pancreatic Tumors Other than Common Ductal Adenocarcinoma. Pancreatology 9:1-2, pages 25-33.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.